Download PDF
Homœopathic Links 2014; 27(3): 136-139
DOI: 10.1055/s-0034-1368651
PHILOSOPHY AND DISCUSSION
Sonntag Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Mechanisms behind Interindividual Variations in Diseases

Their Implication in the Genesis of Peculiar Symptoms in Classical Homeopathy
Mohit Mathur , India
Further Information

Publication History

Publication Date:
27 August 2014 (online)

    Permissions and Reprints

Summary

I discovered a fundamental difference between Kentʼs and Hahnemannʼs concepts of disease, which has undervalued the importance of disease pathophysiology in homeopathic therapeutics. I argue that biological mechanisms operating behind interindividual variations in disease can explain those symptoms, which are peculiar to a patient. My study shows that interindividual variations in diseases arise due to multiple factors including interindividual variability in vascular supply, influence of pharmacological agents, age factor and interindividual variations in host immunogenetic factors. These factors contribute to individual specific pathophysiologic mechanisms, which give rise to individual specific clinical features. Knowledge of these mechanisms can overcome limitations associated with clinical features.

Key words

Kentʼs theory - MHC (Major Histocompatibility Complex) - Peculiar symptoms - Interindividual variations
 

  • References

  • 1 Roberts HA. The Chief Complaint and the Auxiliary Symptoms in Their Relation to the Case. The Principles and Art of Cure by Homoeopathy (reprint edition). New Delhi: B. Jain Publishers (P) Ltd.; 1993: 101
    Google Scholar
  • 2 Kent JT. The Examination of the Patient. Lectures on Homoeopathic Philosophy (reprint edition). New Delhi: B. Jain Publishers (P) Ltd.; 1991: 162
    Google Scholar
  • 3 Green JM. How to prescribe homoeopathic drugs. The Homoeopathic Recorder 1904; XLIII: 396-401
    PubMedGoogle Scholar
  • 4 Walach H, Hausler W, Lowes T et al. Classical homoeopathic treatment of chronic headaches. Cephalalgia 1997; 17: 119-126
    CrossrefPubMedGoogle Scholar
  • 5 Peter F. An experimental double-blind clinical trial method in homoeopathy: use of a limited range of remedies to treat fibrositis. Br Hom J 1986; 75: 142-147
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Andrade LEC, Ferraz MB, Atra E et al. A randomized controlled trial to evaluate the effectiveness of homoeopathy in rheumatoid arthritis. Scand J Rheumatology 1991; 20: 204-208
    CrossrefPubMedGoogle Scholar
  • 7 Gibson RG, Gibson SLM, MacNeill AD et al. Homoeopathic therapy in rheumatoid arthritis: evaluation of double-blind clinical trial. Br J Clin Pharmac 1980; 9: 453-459
    CrossrefPubMedGoogle Scholar
  • 8 Hahnemann S. Organon of Medicine (6th ed.). New Delhi: B. Jain Publishers (P) Ltd.; 1993. 160. 169-171
    Google Scholar
  • 9 Hayreh SS. The optic nerve head circulation in health and disease. Exp Eye Res 1995; 61: 259-272
    CrossrefPubMedGoogle Scholar
  • 10 Zwan A, Hillen B. Review of the variability of the territories of the major cerebral arteries. Stroke 1991; 22: 1078-1084
    CrossrefPubMedGoogle Scholar
  • 11 Smith WS, Hauser SL, Easton JD. Cerebrovascular Diseases. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrisonʼs Principles of Internal Medicine (15th ed.), Vol. II. New Delhi: McGraw-Hill; 2001: 2372
    Google Scholar
  • 12 Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888
    CrossrefPubMedGoogle Scholar
  • 13 Cappell MS, Schein JR. Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity. Gastroenterol Clin North Am 2000; 29: 97-124
    CrossrefPubMedGoogle Scholar
  • 14 Miller D, Yoshikawa T, Castle SC et al. Effect of age on fever response to recombinant tumor necrosis factor alpha in murine models. J Gerontol 1991; 46: M176-M179
    CrossrefPubMedGoogle Scholar
  • 15 Gleckman R, Hibert D. Afebrile bacteremia a phenomenon in geriatric patients. JAMA 1982; 248: 1478-1481
    CrossrefPubMedGoogle Scholar
  • 16 Finkelstein MS, Petkum WM, Freedman ML et al. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc 1983; 31: 19-27
    CrossrefPubMedGoogle Scholar
  • 17 Tiwari J, Terasaki P. The HLA Complex. HLA and Disease Associations, Overview. New York: Springer; 1985: 8-13 43–48
    CrossrefGoogle Scholar
  • 18 Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. CMR 2009; 22: 370-385
    CrossrefPubMedGoogle Scholar
  • 19 Danis VA, Millington M, Hyland VJ et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-310
    PubMedGoogle Scholar
  • 20 Molvig J, Baek J, Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988; 27: 705-716
    CrossrefPubMedGoogle Scholar
  • 21 Saurez A, Castro P, Alonso R et al. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003; 75: 711-717
    CrossrefPubMedGoogle Scholar
  • 22 Kotb M, Norrby-Teglund A, McGeer A et al. Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience. Scand J Infect Dis 2003; 35: 665-669
    CrossrefPubMedGoogle Scholar
  • 23 Kotb M, Norrby-Teglund A, McGeer A et al. An immunogenetic and molecular basis for differences in outcomes of invasive group a streptococcal infections. Nature Medicine 2002; 8: 1398-1404
    CrossrefPubMedGoogle Scholar
  • 24 McGuire W, Hill AVS, Allsopp CEM et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511
    CrossrefPubMedGoogle Scholar
  • 25 Grau GE, Taylor TE, Med MT et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320: 1586-1591
    CrossrefPubMedGoogle Scholar
  • 26 Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264
    CrossrefPubMedGoogle Scholar
  • 27 Conna UV, Fazou C, Cameron B et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004; 34: 1289-1297
    CrossrefPubMedGoogle Scholar
  • 28 Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanism and implications. Trends Neurosci 2002; 25: 154-159
    CrossrefPubMedGoogle Scholar
  • 29 Cleeland HS, Bennett GJ, Dantzer R et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003; 97: 2919-2925
    CrossrefPubMedGoogle Scholar
  • 30 Miaskowski C, Dodd M, Lee K et al. Preliminary evidence of an association between a functional IL6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. J Pain Symptom Manage 2010; 40: 531-544
    CrossrefPubMedGoogle Scholar
  • 31 Kiecolt-Glaser JK, Preacher KJ, MacCallum RC et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. PNAS 2003; 100: 9090-9095
    CrossrefPubMedGoogle Scholar
  • 32 Maes M, Lin AH, Delmeire L et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999; 45: 833-839
    CrossrefPubMedGoogle Scholar
  • 33 Lutgendorf SK, Garand L, Buckwalter KC et al. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol 1999; 54A: M434-M439
    PubMedGoogle Scholar